Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice

Morus albaextract modulates blood pressure homeostasis through eNOS signaling

(2016) Albino Carrizzo et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Cardiac Dysfunction in the BACHD Mouse Model of Huntington’s Disease

(2016) Analyne M. Schroeder et al.   PLoS One

Impaired Nitric Oxide Mediated Vasodilation In The Peripheral Circulation In The R6/2 Mouse Model Of Huntington’s Disease

(2016) Andrew D. Kane et al.   Scientific Reports

Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

(2015) Janelle Drouin-Ouellet et al.   ANNALS OF NEUROLOGY

Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias

(2014) Mark J. Shen et al.   CIRCULATION RESEARCH

Nitric Oxide Dysregulation in Platelets from Patients with Advanced Huntington Disease

(2014) Albino Carrizzo et al.   PLoS One

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease

(2014) Michal Mielcarek et al.   PLoS Genetics

FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease

(2013) Alba Di Pardo et al.   HUMAN MOLECULAR GENETICS

Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols

(2012) Annalisa Aggio et al.   EUROPEAN JOURNAL OF NUTRITION

Late onset vascular dysfunction in the R6/1 model of Huntington’s disease

(2012) Awahan Rahman et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease

(2012) Helen Kiriazis et al.   JOURNAL OF PHYSIOLOGY-LONDON

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

(2012) A. Di Pardo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease

(2011) Damian M. Cummings et al.   JOURNAL OF NEUROPHYSIOLOGY

Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease

(2011) Bin Tang et al.   NEUROBIOLOGY OF DISEASE

Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease

(2010) N. A. Aziz et al.   EUROPEAN JOURNAL OF NEUROLOGY

Autonomic dysfunction in presymptomatic and early symptomatic Huntington’s disease

(2009) J. Kobal et al.   ACTA NEUROLOGICA SCANDINAVICA